OLVIG
AMLX icon

Oliver Lagore Vanvalin Investment Group’s Amylyx Pharmaceuticals AMLX Stock Holding History

Oliver Lagore Vanvalin Investment Group’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$4.16K Sell
1,100
-500
-31% -$2.35K ﹤0.01% 532
2024
Q3 		$5.18K Buy
+1,600
New +$3.6K ﹤0.01% 502

Other funds holding AMLX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

Oliver Lagore Vanvalin Investment Group's AMLX Position: Q4 2024 in Review

Oliver Lagore Vanvalin Investment Group reduced its Amylyx Pharmaceuticals (AMLX) stake by 31% in Q4 2024, selling an estimated $2.35K and leaving 1,100 shares worth $4.16K. The position accounts for ﹤0.01% of the portfolio, ranked #532.

Oliver Lagore Vanvalin Investment Group first reported a position in AMLX in Q3 2024 and has held it in 2 quarters since. The position peaked at $5.18K in Q3 2024. 122 funds tracked by Wall St. Rank hold AMLX as of Q4 2024.

  • Oliver Lagore Vanvalin Investment Group held 1,100 shares of Amylyx Pharmaceuticals worth $4.16K as of Q4 2024.
  • Oliver Lagore Vanvalin Investment Group sold 500 Amylyx Pharmaceuticals shares in Q4 2024, an estimated $2.35K.
  • Amylyx Pharmaceuticals made up ﹤0.01% of Oliver Lagore Vanvalin Investment Group's portfolio in Q4 2024, its #532 holding.
  • Oliver Lagore Vanvalin Investment Group first reported a position in Amylyx Pharmaceuticals in Q3 2024 and has held it in 2 quarters since.
  • Oliver Lagore Vanvalin Investment Group's Amylyx Pharmaceuticals position peaked at $5.18K in Q3 2024.
  • 122 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q4 2024.

Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q4 2024, filed 1 Apr 2025.